The power of a zero CAC score is facing fresh scrutiny after new plaque analysis data presented at SCCT 2026 shows just how much noncalcified plaque confers its own cardiovascular risk, despite the software’s financial barriers. To test whether quantitative plaque assessment can address this, researchers analyzed 3.7k PROMISE patients who were evaluated with CCTA […] The post Zero CAC And The Cost of CCTA-QPA appeared first on Cardiac Wire .